{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:03:35Z","timestamp":1791234215330,"version":"4.1.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:00Z","timestamp":1620950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"\n Background<\/jats:title>\n The systemic immune-inflammation index (SII), which is calculated using absolute platelet, neutrophil, and lymphocyte counts, has recently attracted attentions as a prognostic indicator in patients with solid malignancies. In the current study, we retrospectively investigated the prognostic significance of pre-treatment SII among patients with endometrial cancer.<\/jats:p>\n <\/jats:sec>\n \n Method<\/jats:title>\n Endometrial cancer patients treated at Nara medical university hospital between 2008 and 2018 were included in the current study. Receiver operating characteristic (ROC) curve was used to find the optimal SII cut-off values for 3-years progression free survival (PFS) and overall survival (OS). Then, the predictive abilities of SII and its superiority over neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were investigated. Kaplan-Meier method was used to calculate the OS and PFS rates, and log-rank test was used to compare the survival rate between two groups. Univariate and multivariate Cox regression analysis were performed to identify risk factors for PFS and OS.<\/jats:p>\n <\/jats:sec>\n \n Result<\/jats:title>\n \n A total of 442 patients were included in the current study. The cut-off value of SII for predicting PFS and OS were defined by ROC analysis as 931 and 910, respectively. Univariate analyses showed that elevated SII was associated with significantly shorter survival (\n p<\/jats:italic>\n <0.001 for both PFS and OS). Cox regression analyses revealed that an advanced FIGO stage (\n p<\/jats:italic>\n <0.001 for both PFS and OS) and an elevated SII (\n p<\/jats:italic>\n = 0.014 for PFS,\n p<\/jats:italic>\n = 0.011 for OS) are the independent prognostic factors for survival. When SII was compared with NLR and PLR, SII showed greater area under curve for predicting survival.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n The SII is an independent prognostic factor in endometrial cancer patients, allowing more precise survival estimation than PLR or NLR.<\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0248871","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T13:25:41Z","timestamp":1620998741000},"page":"e0248871","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4323-5470","authenticated-orcid":true,"given":"Sho","family":"Matsubara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1803-1166","authenticated-orcid":true,"given":"Seiji","family":"Mabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8124-6269","authenticated-orcid":true,"given":"Hiroshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,5,14]]},"reference":[{"key":"pone.0248871.ref001","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"F Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"pone.0248871.ref002","unstructured":"Japan Society of Obstetrics and Gynecology. Patient Annual Report for 2017. 2017. http:\/\/fa.kyorin.co.jp\/jsog\/readPDF.php?file=71\/5\/071050669.pdf, accessed on February 13, 2020."},{"key":"pone.0248871.ref003","unstructured":"Cancer Registry and Statistics. Cancer Information Service, National Cancer Center, Japan (Vital Statistics of Japan). 2017. https:\/\/ganjoho.jp\/reg_stat\/statistics\/dl\/index.html#mortality, accessed on February 13, 2020."},{"key":"pone.0248871.ref004","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0020-7292(06)60031-3","article-title":"Carcinoma of the corpus uteri","volume":"95","author":"W Creasman","year":"2006","journal-title":"Int J Gynecol Obstet"},{"key":"pone.0248871.ref005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ygyno.2007.04.032","article-title":"Importance of histology in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study","volume":"106","author":"S McMeekin","year":"2007","journal-title":"Gynecol Oncol"},{"key":"pone.0248871.ref006","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and post-operative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicenter randomized trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"CL Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"pone.0248871.ref007","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00006250-198309000-00019","article-title":"Malignant peritoneal cytology as an indicator in stage I endometrial cancer","volume":"62","author":"R Yazigi","year":"1983","journal-title":"Obstet Gynecol"},{"key":"pone.0248871.ref008","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0090-8258(90)90116-3","article-title":"Prognostic value of peritoneal cytology in endometrial carcinoma","volume":"36","author":"R Grimshaw","year":"1990","journal-title":"Gynecol Oncol"},{"key":"pone.0248871.ref009","first-page":"21","article-title":"The Significance of positive peritoneal cytology in endometrial cancer","volume":"4","author":"GP Sutton","year":"1990","journal-title":"Oncology"},{"key":"pone.0248871.ref010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2006.08.027","article-title":"The prognostic significance of positive peritoneal cytology and adnexal\/serosal metastasis in stage III a endometrial cancer","volume":"104","author":"L Havrilesky","year":"2007","journal-title":"Gynecol Oncol"},{"key":"pone.0248871.ref011","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ygyno.2011.09.017","article-title":"Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer","volume":"124","author":"S Guntupalli","year":"2012","journal-title":"Gynecol Oncol"},{"key":"pone.0248871.ref012","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"SI Grivennikov","year":"2010","journal-title":"Cell"},{"key":"pone.0248871.ref013","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/nu7042589","article-title":"Inflammaging and Cancer: A Challenge for the Mediterranean Diet","volume":"7","author":"R Ostan","year":"2015","journal-title":"Nutrients"},{"key":"pone.0248871.ref014","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/bjc.2015.200","article-title":"Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival","volume":"113","author":"M Cummings","year":"2015","journal-title":"Br J Cancer"},{"key":"pone.0248871.ref015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00404-019-05372-w","article-title":"Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis","volume":"301","author":"L Ni","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"pone.0248871.ref016","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"B Hu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"pone.0248871.ref017","doi-asserted-by":"crossref","first-page":"39482","DOI":"10.1038\/srep39482","article-title":"Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous cell Carcinoma: A Propensity Score-matched analysis","volume":"6","author":"Y Geng","year":"2016","journal-title":"Sci Rep"},{"key":"pone.0248871.ref018","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jtho.2016.06.019","article-title":"Assessment of Lymph Node Ratio to Relapse the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma","volume":"11","author":"Y Shao","year":"2016","journal-title":"J Thorac Oncol"},{"key":"pone.0248871.ref019","doi-asserted-by":"crossref","first-page":"33210","DOI":"10.18632\/oncotarget.8901","article-title":"Inflammatory indexes as predictors of prognostic and bevacizumab efficiency in patients with metastatic colorectal cancer","volume":"7","author":"A Passardi","year":"2016","journal-title":"Oncotarget"},{"key":"pone.0248871.ref020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1620\/tjem.236.297","article-title":"Systemic Immune-Inflammation Index Based on Platelet Counts and Neutrophil-Lymphocyte Ratio, Is Useful for predicting Prognosis in Small Cell Lung Cancer","volume":"236","author":"X Hong","year":"2015","journal-title":"Tohoku J Exp Med"},{"key":"pone.0248871.ref021","doi-asserted-by":"crossref","first-page":"572","DOI":"10.21037\/atm.2019.09.18","article-title":"Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer","volume":"7","author":"R Berardi","year":"2019","journal-title":"Ann Transl Med"},{"key":"pone.0248871.ref022","doi-asserted-by":"crossref","first-page":"965","DOI":"10.21037\/jgo.2019.05.03","article-title":"The prognostic value of systemic immune-inflammation index(SII) in patients after radical operation for carcinoma of stomach in gastric cancer","volume":"10","author":"Q Whang","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"pone.0248871.ref023","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2147\/CMAR.S151026","article-title":"Systemic Immune-Inflammation Index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy","volume":"9","author":"L Chen","year":"2017","journal-title":"Cancer Manag Res"},{"key":"pone.0248871.ref024","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1245\/s10434-019-08094-0","article-title":"Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer","volume":"27","author":"P Murthy","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"pone.0248871.ref025","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.2147\/CMAR.S197623","article-title":"Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer","volume":"11","author":"J Liu","year":"2019","journal-title":"Cancer Manag Res"},{"key":"pone.0248871.ref026","doi-asserted-by":"crossref","first-page":"431","DOI":"10.21037\/atm.2019.09.02","article-title":"Systemic immune-inflammation index predicts prognosis of bladder cancer patients after radical cystectomy","volume":"7","author":"W Zhang","year":"2019","journal-title":"Ann Transl Med"},{"key":"pone.0248871.ref027","doi-asserted-by":"crossref","first-page":"105397","DOI":"10.1016\/j.clineuro.2019.105397","article-title":"The prognostic role of preoperative systemic immune-inflammation index and albumin\/globulin ratio in patients with newly diagnosed high-grade glioma","volume":"184","author":"R Liang","year":"2019","journal-title":"Clin Neurol Neurosurg"},{"key":"pone.0248871.ref028","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2217\/bmm-2019-0303","article-title":"Systemic immune-inflammation index predicting survival outcome in patients with classical Hodgikin lymphoma","volume":"13","author":"C Mirli","year":"2019","journal-title":"Biomark Med"},{"key":"pone.0248871.ref029","first-page":"2127","article-title":"A novel predictor in patients with gastrointestinal stromal tumors: Systemic immune-inflammation index(SII)","volume":"24","author":"A Yilmaz","year":"2019","journal-title":"J BUON"},{"key":"pone.0248871.ref030","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1038\/s41598-019-39150-0","article-title":"Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients with Cervical Cancer","volume":"9","author":"H Huang","year":"2019","journal-title":"Sci Rep"},{"issue":"9","key":"pone.0248871.ref031","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3390\/jcm9051441","article-title":"Analysis of Systemic Inflammatory Factors and Survival Outcomes in Endometrial Cancer Patients Staged I-III FIGO and Treated with Postoperative External Radiotherapy","volume":"12","author":"K Holub","year":"2020","journal-title":"J Clin Med"},{"key":"pone.0248871.ref032","doi-asserted-by":"crossref","first-page":"351","DOI":"10.36472\/msd.v7i1.339","article-title":"Inflammatory prognostic markers in endometrial carcinoma: Systemic immune-inflammation index and prognostic nutritional index","volume":"7","author":"C Mirili","year":"2020","journal-title":"Med Sci Discov"},{"key":"pone.0248871.ref033","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/cas.13101","article-title":"Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients","volume":"107","author":"R Ogiya","year":"2016","journal-title":"Cancer Sci"},{"key":"pone.0248871.ref034","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1200\/JCO.2010.27.9992","article-title":"Dual roles for immunity in gastrointestinal cancers","volume":"28","author":"C Ferrone","year":"2010","journal-title":"J Clin Oncol"},{"key":"pone.0248871.ref035","first-page":"8.e1662708","article-title":"The role of myeloid-derived suppressor cells in endometrial cancer displaying systemic inflammatory response: clinical and preclinical investigations","author":"E Yokoi","year":"2019","journal-title":"Oncoimmunology"},{"key":"pone.0248871.ref036","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1182\/blood-2012-11-466532","article-title":"Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF-A bioavailability and secreting VEGF-D","volume":"122","author":"K Tan","year":"2013","journal-title":"Blood"},{"key":"pone.0248871.ref037","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/B:AGEN.0000029415.62384.ba","article-title":"Platelets and granulocytes, in particular the neutrophils, from important compartments for circulating vascular endothelial growth factor","volume":"6","author":"Y Kusumanto","year":"2003","journal-title":"Angiogenesis"},{"key":"pone.0248871.ref038","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3844\/ajisp.2009.29.49","article-title":"The tumor\/immune interface: clinical evidence of cancer immunosurveillance, immunoediting and immunosubversion","volume":"5","author":"MS Block","year":"2009","journal-title":"Am J Immunol"},{"key":"pone.0248871.ref039","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","article-title":"Paraneoplastic Thrombocytosis in Ovarian Cancer","volume":"366","author":"R Stone","year":"2012","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0248871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T13:26:10Z","timestamp":1620998770000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0248871"}},"subtitle":[],"editor":[{"given":"Julia","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,5,14]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0248871","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,14]]}}}